Medtronic misses mark in Q4 as sales decline 26%

Medtronic misses mark in Q4 as sales decline 26%

Source: 
Mass Device
snippet: 

Medtronic (NYSE:MDT) announced fourth-quarter results today that were even worse than expected, but the world’s largest medical device company is still upping its dividend and investing in future growth.